List of Tables
Table 1: Multiple Myeloma Therapeutics Market, Initial Screening in Suspected Myeloma Patients 13
Table 2: Multiple Myeloma Therapeutics Market, Diagnostic Criteria for MGUS, Asymptomatic Myeloma and Symptomatic Myeloma 14
Table 3: Multiple Myeloma Therapeutics Market, Myeloma-Related Organ or Tissue Impairment 14
Table 4: Multiple Myeloma Therapeutics Market, Disease Staging, Durie-Salmon Staging System 16
Table 5: Multiple Myeloma Therapeutics Market, Prognostic Factors 18
Table 6: Multiple Myeloma Therapeutics Market, Prognostic Factors 19
Table 7: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Discovery, 2015 95
Table 8: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Preclinical, 2015 97
Table 9: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, IND/CTA-filed, 2015 100
Table 10: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Phase I, 2015 101
Table 11: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Phase II, 2015 104
Table 12: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Phase III, 2015 107
Table 13: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Pre-registration, 2015 107
Table 14: Multiple Myeloma Therapeutics Market, Asia-Pacific, Market Forecast, 2014–2021 108
Table 15: Multiple Myeloma Therapeutics Market, India, Market Forecast, 2014–2021 108
Table 16: Multiple Myeloma Therapeutics Market, China, Market Forecast, 2014–2021 109
Table 17: Multiple Myeloma Therapeutics Market, Australia, Market Forecast, 2014–2021 109
Table 18: Multiple Myeloma Therapeutics Market, Japan, Market Forecast, 2014–2021 110